China SXT Pharmaceuticals, Inc. SXTC
Set alert
2.78 USD -0.47 -14.46%
At close · Nov 2
2.79 +0.01 +0.36%
After hours · Nov 2, 4:00 PM ET
2.77 Day range 3.12
2.77 52-week range 8,376,000.00
- YTD
- -100.00%
- 1 year
- -100.00%
- Open
- 3.12
- Prev close
- 3.25
- Mkt cap
- 287.94K
- Vol
- 74.12K
- Avg vol
- 224.22K
- EPS
- -73,040.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.77
- High
- 3.12
- Forward P/E
- 0.00
- Beta
- 1.16
- Short ratio
- 0.52
- Inst. own
- 1.35%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.47092
- 200-d avg
- 0.939895
- 1y target
- 0.00
5D chart
Signals (109)
| Name | Time | Ago |
|---|---|---|
| SMA: Bearish | Nov 2, 12:15 PM | 17 hours ago |
| SMA: Bearish | Nov 2, 12:15 PM | 17 hours ago |
| SMA: Bullish | Nov 2, 11:45 AM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 11:20 AM | 18 hours ago |
| MACD: Sell Signal | Nov 2, 11:15 AM | 18 hours ago |
| MACD: Buy Signal | Nov 2, 10:45 AM | 19 hours ago |
| SMA: Bullish | Nov 2, 10:25 AM | 19 hours ago |
| RSI: Oversold | Nov 2, 9:45 AM | 20 hours ago |
| MACD: Sell Signal | Nov 2, 9:35 AM | 20 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 20 hours ago |
| SMA: Bearish | Nov 2, 9:30 AM | 20 hours ago |
| RSI: Overbought | Oct 30, 3:35 PM | 3 days ago |
| SMA: Bullish | Oct 30, 2:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 30, 1:50 PM | 3 days ago |
| SMA: Bearish | Oct 30, 12:40 PM | 3 days ago |
| SMA: Bearish | Oct 30, 11:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 30, 11:50 AM | 3 days ago |
| SMA: Bullish | Oct 30, 11:25 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
| SMA: Bearish | Oct 30, 11:20 AM | 3 days ago |
Newest 20 of 109.
Financial health
Altman Z-Score
-0.76 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
B-3 / 5 overall
- DCF 5
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 3
Valuation
P/E -14.7×
FY 2017 5y median -30618× FY 2026
P/S 85.2×
FY 2017 5y median 71677× FY 2026
P/B 3.1×
FY 2017 5y median 9923× FY 2026
P/FCF -22.7×
FY 2017 5y median -71431× FY 2026
EV/EBITDA -9.2×
FY 2017 5y median -34893× FY 2026
EV/Sales 59.9×
FY 2017 5y median 71672× FY 2026
FCF Yield -4.4%
FY 2017 5y median -0.0% FY 2026
Profitability
Gross Margin 17.1%
FY 2017 5y median 21.6% FY 2026
Operating Margin -664.1%
FY 2017 5y median -199.4% FY 2026
Net Margin -578.5%
FY 2017 5y median -220.4% FY 2026
ROE -20.9%
FY 2017 5y median -22.2% FY 2026
ROIC -23.1%
FY 2017 5y median -19.1% FY 2026
ROA -17.9%
FY 2017 5y median -17.1% FY 2026
Growth (YoY)
Revenue -38.4%
FY 2017 FY 2026
Operating Income -165.7%
FY 2017 FY 2026
EPS (diluted) -11.6%
FY 2017 FY 2026
Free Cash Flow -71.1%
FY 2017 FY 2026
Financial Health
Current Ratio 7.9×
FY 2017 5y median 1.6× FY 2026
Quick Ratio 7.3×
FY 2017 5y median 1.5× FY 2026
Debt / Equity 0.0×
FY 2017 5y median 0.2× FY 2026
Net Debt / EBITDA 3.9×
FY 2017 5y median 3.9× FY 2026
Interest Coverage -113×
FY 2017 5y median -11.8× FY 2026
Dividends
Dividend Yield 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017 5y median 0.0% FY 2026
Annual · latest fiscal year ends 2026-03-31
